Purchase Order 75N91021P00160
Award Date 1/9/21
Potential Completion Date 1/8/23
Potential Value $198K
Federal Agency
Awardee
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $24,999 firm fixed price purchase order to Bruker Biospin Corp for a service agreement on a Bruker Avance NEO 700 NMR spectrometer. Performance will take place in Rockville, Maryland through May 2024. Bruker Corporation is the parent company of Bruker Biospin Corp, the prime contractor. No set-aside designation was used for this procurement to deliver maintenance and support services...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $24,880.80 firm fixed price purchase order to Bruker Biospin Corp. for a service agreement for the Bruker AVANCE NEO 700 NMR spectrometer. The prime contractor, Bruker Biospin Corp., a subsidiary of Bruker Corporation, will provide maintenance and support services for the NMR spectrometer located in Rockville, Maryland over a period of three months from September 4, 2023 through December...
- This firm fixed-price purchase order was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute (NCI) to Bruker Biospin Corp, a manufacturer of scientific instruments. The $248,808.00 contract is for preventive and emergency maintenance and support services for one government-owned Bruker Avance Neo 700 nuclear magnetic resonance (NMR) spectrometer, in support of the NCI's Center for Cancer Research (CCR) Urologic Oncology...
- The National Cancer Institute (NCI) awarded a firm fixed-price purchase order to Bruker Biospin Corp for preventative maintenance services on specialized scientific equipment, with a ceiling value of approximately $286K and an ultimate completion date of March 13, 2028. The contract covers maintenance for one Bruker AVANCE NEO 700 MHz Nuclear Magnetic Resonance (NMR) spectrometer with LabScape Complete integration and one Bruker preclinical BioSpec 3T Magnetic Resonance Imaging (MRI) system,...
- This firm-fixed-price purchase order was awarded by the National Institutes of Health (NIH) National Cancer Institute (NCI) to Bruker Biospin Corp, a manufacturer of scientific instruments, to acquire a new 700-megahertz nuclear magnetic resonance (NMR) spectrometer for metabolomics analyses at the Center for Cancer Metabolism. The $2,035,930 contract has a completion date of September 21, 2019 and does not utilize a set-aside designation. Bruker Biospin Corp has previously provided NMR...
- This is a firm-fixed price purchase order award from the Department of Health and Human Services National Institutes of Health National Cancer Institute to Bruker Biospin Corp, a manufacturer of scientific instruments, for preventive maintenance services on a government-owned 700 MHz nuclear magnetic resonance (NMR) spectrometer console. The potential value of the contract is $118,196.11. There was no set-aside designation for this contract. Bruker Biospin Corp provides specialized equipment,...
- The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI) awarded a $158,684.80 firm fixed-price purchase order to Bruker Biospin Corp, a manufacturer of scientific instruments, for maintenance services on a government-owned Bruker preclinical magnetic resonance imaging (MRI) system used by the NCI's Center for Cancer Research (CCR). The purchase order will enable Bruker, the original equipment manufacturer, to provide regular...
- This firm-fixed-price purchase order contract, awarded by the National Cancer Institute (NCI) to Bruker Biospin Corp, is valued at $369,168.00 and has an ultimate completion date of September 21, 2025. The contract is for the maintenance and preventive maintenance of a government-owned 700 MHz nuclear magnetic resonance (NMR) spectrometer console. This contract does not utilize any set-aside designations. Bruker Biospin Corp is a subsidiary of Bruker Scientific LLC, a prominent manufacturer of...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $17,015 purchase order to Bruker Biospin Corp. for maintenance services. Bruker Biospin Corp. will provide maintenance for scientific equipment located at the agency's facility in Bethesda, Maryland over a one-year base period of performance from August 2023 through August 2024. The contract is a firm fixed price agreement with Bruker Corporation, the parent company of Bruker Biospin...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Cancer Institute (NCI) to Bruker Biospin Corp, a manufacturer of scientific instruments. The purpose is to acquire a full coverage maintenance service contract covering a 700 MHz nuclear magnetic resonance (NMR) spectrometer console, which is essential for research at the NCI's Laboratory of Biochemistry and Molecular Biology. The contract has a...